Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/47832
Type
ArticleCopyright
Open access
Collections
- AM - ILMD - Artigos de Periódicos [357]
- IFF - Artigos de Periódicos [1300]
- INI - Artigos de Periódicos [3646]
- MG - IRR - Artigos de Periódicos [4307]
Metadata
Show full item record
WHY DID ZIKV PERINATAL OUTCOMES DIFFER IN DISTINCT REGIONS OF BRAZIL? AN EXPLORATORY STUDY OF TWO COHORTS
Author
Damasceno, Luana
Terzian, Ana Carolina B.
Fuller, Trevon
Estofolete, Cassia F.
Andrade, Adriana
Kroon, Erna G.
Zin, Andrea A.
Vasconcelos, Zilton Farias Meira de
Pereira Jr, Jose P.
Castilho, Márcia C.
Piaulino, Isa Cristina R.
Vasilakis, Nikos
Moreira, Maria E.
Nielsen-Saines, Karin
Espinosa, Flor E. Martinez
Nogueira, Maurício L.
Brasil, Patricia
Terzian, Ana Carolina B.
Fuller, Trevon
Estofolete, Cassia F.
Andrade, Adriana
Kroon, Erna G.
Zin, Andrea A.
Vasconcelos, Zilton Farias Meira de
Pereira Jr, Jose P.
Castilho, Márcia C.
Piaulino, Isa Cristina R.
Vasilakis, Nikos
Moreira, Maria E.
Nielsen-Saines, Karin
Espinosa, Flor E. Martinez
Nogueira, Maurício L.
Brasil, Patricia
Affilliation
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de doenças febris agudas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. René Rachou Institute. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de doenças febris agudas. Rio de Janeiro, RJ, Brasil.
School of Medicine (FAMERP). Laboratory of Virology. São José do Rio Preto, SP, Brazil.
Federal University of Minas Gerais. Institute of Biological Sciences. Belo Horizonte, MG, Brazil.
Federal University of Minas Gerais. Institute of Biological Sciences. Belo Horizonte, MG, Brazil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Dr. Heitor Vieira Dourado Tropical Medicine Foundation. Department of Virology. Manaus, AM, Brazil.
Amazonas State University. Postgraduate Program in Tropical Medicine. Manaus, AM, Brazil.
University of Texas Medical Branch. Department of Pathology. Galveston, TX, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
University of California. David Geffen School of Medicine. Department of Pediatrics. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Leônidas & Maria Deane. Laboratório de Território, Meio Ambiente, Saúde e Sustentabilidade. Manaus, AM, Brasil / Fundação Dr. Heitor Vieira Dourado de Medicina Tropical. Departamento de Malária. Manaus, AM, Brasil.
School of Medicine (FAMERP). Laboratory of Virology. São José do Rio Preto, SP, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de doenças febris agudas. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. René Rachou Institute. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de doenças febris agudas. Rio de Janeiro, RJ, Brasil.
School of Medicine (FAMERP). Laboratory of Virology. São José do Rio Preto, SP, Brazil.
Federal University of Minas Gerais. Institute of Biological Sciences. Belo Horizonte, MG, Brazil.
Federal University of Minas Gerais. Institute of Biological Sciences. Belo Horizonte, MG, Brazil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
Dr. Heitor Vieira Dourado Tropical Medicine Foundation. Department of Virology. Manaus, AM, Brazil.
Amazonas State University. Postgraduate Program in Tropical Medicine. Manaus, AM, Brazil.
University of Texas Medical Branch. Department of Pathology. Galveston, TX, USA.
Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Rio de Janeiro, RJ, Brasil.
University of California. David Geffen School of Medicine. Department of Pediatrics. Los Angeles, CA, USA.
Fundação Oswaldo Cruz. Instituto Leônidas & Maria Deane. Laboratório de Território, Meio Ambiente, Saúde e Sustentabilidade. Manaus, AM, Brasil / Fundação Dr. Heitor Vieira Dourado de Medicina Tropical. Departamento de Malária. Manaus, AM, Brasil.
School of Medicine (FAMERP). Laboratory of Virology. São José do Rio Preto, SP, Brazil.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de doenças febris agudas. Rio de Janeiro, RJ, Brasil.
Abstract
The Zika virus (ZIKV) epidemic in Brazil occurred in regions where dengue viruses (DENV) are historically endemic. We investigated the differences in adverse pregnancy/infant outcomes in two cohorts comprising 114 pregnant women with PCR-confirmed ZIKV infection in Rio de Janeiro, Southeastern Brazil (n = 50) and Manaus, in the north region of the country (n = 64). Prior exposure to DENV was evaluated through plaque reduction neutralizing antibody assays (PRNT 80) and DENV IgG serologies. Potential associations between pregnancy outcomes and Zika attack rates in the two cities were explored. Overall, 31 women (27%) had adverse pregnancy/infant outcomes, 27 in Rio (54%) and 4 in Manaus (6%), p < 0.001. This included 4 pregnancy losses (13%) and 27 infants with abnormalities at birth (24%). A total of 93 women (82%) had evidence of prior DENV exposure, 45 in Rio (90%) and 48 in Manaus (75%). Zika attack rates differed; the rate in Rio was 10.28 cases/10,000 and in Manaus, 0.6 cases/10,000, p < 0.001. Only Zika attack rates (Odds Ratio: 17.6, 95% Confidence Interval 5.6-55.9, p < 0.001) and infection in the first trimester of pregnancy (OR: 4.26, 95% CI 1.4-12.9, p = 0.011) were associated with adverse pregnancy and infant outcomes. Pre-existing immunity to DENV was not associated with outcomes (normal or abnormal) in patients with ZIKV infection during pregnancy.
Share